These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 446506)

  • 21. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up.
    Yin H; Leong AS
    Am J Clin Pathol; 2004 May; 121(5):679-87. PubMed ID: 15151208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The natural history of patients less than 40 years old with bladder tumors.
    Kurz KR; Pitts WR; Vaughan ED
    J Urol; 1987 Mar; 137(3):395-7. PubMed ID: 3820365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading.
    Lipponen P; Eskelinen M
    Anticancer Res; 1990; 10(6):1725-30. PubMed ID: 2285249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CLINICO-PATHOLOGICAL PATTERN, CLASSIFICATION AND STAGING OF URINARY BLADDER CARCINOMAS--A FIVE YEARS EXPERIENCE AT A TERTIARY CARE HOSPITAL IN CENTRAL PUNJAB.
    Naeem A; Naseem N; Anwar S; Butt S; Nagi AH
    J Ayub Med Coll Abbottabad; 2015; 27(1):131-4. PubMed ID: 26182758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometry of deparaffinized nuclei compared to histological grading for the pathological evaluation of transitional cell carcinomas.
    Murphy WM; Chandler RW; Trafford RM
    J Urol; 1986 Apr; 135(4):694-7. PubMed ID: 3959188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urothelial tumours of the urinary bladder: a histopathological study of cystoscopic biopsies.
    Vaidya S; Lakhey M; K C S; Hirachand S
    JNMA J Nepal Med Assoc; 2013; 52(191):475-8. PubMed ID: 24907954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting the outcome of radical radiotherapy for invasive bladder cancer.
    Vale JA; A'Hern RP; Liu K; Hendry WF; Whitfield HN; Plowman PN; Sowter C; Slavin G
    Eur Urol; 1993; 24(1):48-51. PubMed ID: 8365439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-specific survival by stage of bladder cancer and factors collected by Mallorca Cancer Registry associated to survival.
    Ripoll J; Ramos M; Montaño J; Pons J; Ameijide A; Franch P
    BMC Cancer; 2021 Jun; 21(1):676. PubMed ID: 34098901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple analysis of morphologic factors with prognostic value in transitional cell papillary carcinoma of the bladder. Retrospective study of 571 cases].
    Ramos Soler D; Ferrer Lozano J; Navarro Fos S; Llombart-Bosch A
    Actas Urol Esp; 1999 Feb; 23(2):119-26. PubMed ID: 10327675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder.
    Kakizoe T; Tobisu K; Takai K; Tanaka Y; Kishi K; Teshima S
    Cancer Res; 1988 Apr; 48(8):2299-303. PubMed ID: 3349494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in non-infiltrating carcinoma of the bladder: a preliminary report.
    Pocock RD; Ponder BA; O'Sullivan JP; Ibrahim SK; Easton DF; Shearer RJ
    Br J Urol; 1982 Dec; 54(6):711-5. PubMed ID: 7150929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The prognostic aspects of the morphological signs of bladder cancer].
    Ermilova VD; Mustia AI; Figurin KM
    Arkh Patol; 1994; 56(5):65-9. PubMed ID: 7695498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological analysis of high-grade superficial bladder tumour.
    Kubota Y; Numasawa K; Suzuki H; Kakizaki H; Ishii N; Kawamura S; Nakada T; Suzuki K
    Int Urol Nephrol; 1991; 23(3):237-43. PubMed ID: 1889970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Standards and perspectives in diagnosis and therapy of bladder carcinoma].
    Stief C; Zaak D; Stöckle M; Studer U; Knuechel R; Rödel C; Sauer R; Rubben H
    Urologe A; 2006 Sep; 45 Suppl 4():90-6. PubMed ID: 16896761
    [No Abstract]   [Full Text] [Related]  

  • 35. Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer.
    Lipponen PK; Nordling S; Eskelinen MJ; Jauhiainen K; Terho R; Harju E
    Int J Cancer; 1993 Jan; 53(1):42-7. PubMed ID: 8416203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical prognostic factors in transitional cell cancer of the bladder.
    Lipponen PK; Eskelinen M; Jauhiainen K; Terho R; Harju E
    Urol Int; 1993; 50(4):192-7. PubMed ID: 8506588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.
    Raitanen MP; Nieminen P; Tammela TL
    Br J Urol; 1995 Oct; 76(4):470-4. PubMed ID: 7551884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis of transitional cell bladder cancer: a multivariate prognostic score for improved prediction.
    Lipponen PK; Eskelinen MJ; Kiviranta J; Pesonen E
    J Urol; 1991 Dec; 146(6):1535-40. PubMed ID: 1942335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transitional cell carcinomas of the urinary bladder. A histopathological study.
    Ahmed Z; Muzaffer S; Khan M; Kayani N; Pervez S; Husseini AS; Hasan SH
    J Pak Med Assoc; 2002 Sep; 52(9):396-8. PubMed ID: 12532572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of prognosis and clinicopathology of bladder cancer to blood group type of host patients in Japan.
    Yamada T; Fukui I; Yokokawa M; Oshima H
    Scand J Urol Nephrol; 1993; 27(2):199-203. PubMed ID: 8351472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.